Wikidata

(Q40552184)

English

A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer

scientific article published on May 2004

In more languages

Statements

title
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15161690
retrieved
21 September 2017
author name string
Walter M Stadler
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15161690
retrieved
21 September 2017
Dingcai Cao
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15161690
retrieved
21 September 2017
Nicholas J Vogelzang
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15161690
retrieved
21 September 2017
Christopher W Ryan
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15161690
retrieved
21 September 2017
Kristin Hoving
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15161690
retrieved
21 September 2017
Russell Wright
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15161690
retrieved
21 September 2017
Theodore Karrison
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15161690
retrieved
21 September 2017
publication date
1 May 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15161690
retrieved
21 September 2017
page(s)
3365-3370
1 reference
stated in
Europe PubMed Central
PubMed ID
15161690
retrieved
21 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40552184&oldid=1900278227"